Michael J. Keating

4 ta ish

The University of Texas MD Anderson Cancer Center

1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

   Enli Liu, David Marín, Pinaki P. Banerjee +24

   Maqola20207 iqtibos

   ABIABI:AkademIndex/2026.other.312682

2. Frequent deletions and down-regulation of micro- RNA genes <i>miR15</i> and <i>miR16</i> at 13q14 in chronic lymphocytic leukemia

   George A. Calin, Calin Dan Dumitru, Masayoshi Shimizu +12

   MaqolaOAOchiq kirish20023 iqtibos

   ABIABI:AkademIndex/2026.other.235574

3. The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

   Julia Hoellenriegel, Dirk Zboralski, Christian Maasch +5

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.071984

4. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R–positive CLL cells

   Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du +3

   Maqola20062 iqtibos

   ABIABI:AkademIndex/2026.other.193237